These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24831319)

  • 1. Treatment of notalgia paresthetica with botulinum toxin A: a double-blind randomized controlled trial.
    Maari C; Marchessault P; Bissonnette R
    J Am Acad Dermatol; 2014 Jun; 70(6):1139-41. PubMed ID: 24831319
    [No Abstract]   [Full Text] [Related]  

  • 2. Notalgia paresthetica: treatment using intradermal botulinum toxin A.
    Pérez-Pérez L; García-Gavín J; Allegue F; Caeiro JL; Fabeiro JM; Zulaica A
    Actas Dermosifiliogr; 2014; 105(1):74-7. PubMed ID: 24378421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Notalgia paresthetica: Treatment with botulinum toxin type A].
    Morcillo Pérez C; Guerras Normand I; García Chinchetru MC
    Rehabilitacion (Madr); 2020; 54(2):142-145. PubMed ID: 32370829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin treatment in notalgia paresthetica: a preliminary report.
    Uysal Tan F; Koc RS; Erkek Ozturk Durmaz E; Tuncez Akyurek F
    Int J Dermatol; 2020 Apr; 59(4):e125-e127. PubMed ID: 31646616
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study.
    Rystedt A; Karlqvist M; Bertilsson M; Naver H; Swartling C
    Acta Derm Venereol; 2013 Nov; 93(6):674-8. PubMed ID: 23694974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
    Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
    J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Botulinum Toxin Type A in a Patient With Refractory Itch From Notalgia Paresthetica.
    Datta S; Mahal S; Bhagavan SM; Govindarajan R
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):243-244. PubMed ID: 32453101
    [No Abstract]   [Full Text] [Related]  

  • 9. Notalgia Paresthetica, A Clinical Series and Review.
    Chiriac A; Podoleanu C; Moldovan C; Stolnicu S
    Pain Pract; 2016 Jun; 16(5):E90-1. PubMed ID: 27260118
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
    Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keloid scars and treatment with Botulinum Toxin Type A: the Belfast experience.
    Robinson AJ; Khadim MF; Khan K
    J Plast Reconstr Aesthet Surg; 2013 Mar; 66(3):439-40. PubMed ID: 23092904
    [No Abstract]   [Full Text] [Related]  

  • 12. Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy.
    Loosemore MP; Bordeaux JS; Bernhard JD
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1440-1. PubMed ID: 17958872
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study.
    Ziade M; Domergue S; Batifol D; Jreige R; Sebbane M; Goudot P; Yachouh J
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):209-14. PubMed ID: 23102873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of notalgia paresthetica with botulinum toxin type A.
    Weinfeld PK
    Arch Dermatol; 2007 Aug; 143(8):980-2. PubMed ID: 17709655
    [No Abstract]   [Full Text] [Related]  

  • 17. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.
    Marco E; Duarte E; Vila J; Tejero M; Guillen A; Boza R; Escalada F; Espadaler JM
    J Rehabil Med; 2007 Jul; 39(6):440-7. PubMed ID: 17624477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial.
    Samim M; Twigt B; Stoker L; Pronk A
    Ann Surg; 2012 Jan; 255(1):18-22. PubMed ID: 21685792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
    Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.